Cover Image
Market Research Report

Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019

Published by GlobalData Product code 640278
Published Content info 40 Pages
Delivery time: 1-2 business days
Price
Back to Top
Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019
Published: November 1, 2019 Content info: 40 Pages
Description

GlobalData's Medical Devices sector report, "Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019" provides an overview of Bone Metabolism Assays currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Metabolism Assays pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bone Metabolism Assays under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Metabolism Assays and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bone Metabolism Assays under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0811EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables 3
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 Bone Metabolism Assays Overview 5

3 Products under Development 6

  • 3.1 Bone Metabolism Assays - Pipeline Products by Stage of Development 6
  • 3.2 Bone Metabolism Assays - Pipeline Products by Segment 7
  • 3.3 Bone Metabolism Assays - Pipeline Products by Territory 8
  • 3.4 Bone Metabolism Assays - Pipeline Products by Regulatory Path 9
  • 3.5 Bone Metabolism Assays - Pipeline Products by Estimated Approval Date 10

4 Bone Metabolism Assays - Pipeline Products under Development by Companies 11

  • 4.1 Bone Metabolism Assays Companies - Pipeline Products by Stage of Development 11
  • 4.2 Bone Metabolism Assays - Pipeline Products by Stage of Development 12

5 Bone Metabolism Assays Companies and Product Overview 13

  • 5.1 Alere Inc Company Overview 13
    • 5.1.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.2 AMS Diagnostics LLC Company Overview 14
    • 5.2.1 AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.3 Beckman Coulter Inc Company Overview 16
    • 5.3.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.4 Carolina Liquid Chemistries Corp Company Overview 17
    • 5.4.1 Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.5 DiaSorin SpA Company Overview 19
    • 5.5.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.6 Immunodiagnostic Systems Holdings plc Company Overview 22
    • 5.6.1 Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.7 Novartis AG Company Overview 23
    • 5.7.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.8 OJ-Bio Ltd (Inactive) Company Overview 24
    • 5.8.1 OJ-Bio Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.9 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 25
    • 5.9.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.10 Siemens Healthineers AG Company Overview 30
    • 5.10.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.11 Tosoh Bioscience Inc Company Overview 33
    • 5.11.1 Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 33

6 Bone Metabolism Assays- Recent Developments 34

  • 6.1 Mar 07, 2019: Mindray signs patient safety movement's open data pledge & becomes 90th company to join to improve patient safety 34
  • 6.2 Dec 04, 2018: Mindray international exchange program on hematology: linking medical expertise across borders 34

7 Appendix 37

  • 7.1 Methodology 37
  • 7.2 About GlobalData 40
  • 7.3 Contact Us 40
  • 7.4 Disclaimer 40

List of Tables

  • Table 1: Bone Metabolism Assays - Pipeline Products by Stage of Development 6
  • Table 2: Bone Metabolism Assays - Pipeline Products by Segment 7
  • Table 3: Bone Metabolism Assays - Pipeline Products by Territory 8
  • Table 4: Bone Metabolism Assay

List of Figures

  • Figure 1: Bone Metabolism Assays - Pipeline Products by Stage of Development 6
  • Figure 2: Bone Metabolism Assays - Pipeline Products by Segment 7
  • Figure 3: Bone Metabolism Assays - Pipeline Products by Territory 8
  • Figure 4: Bone Metabolism
Back to Top